Guggenheim Maintains Buy on Exelixis, Raises Price Target to $30
Portfolio Pulse from Benzinga Newsdesk
Guggenheim analyst Michael Schmidt maintains a 'Buy' rating on Exelixis (NASDAQ:EXEL) and raises the price target from $27 to $30.
September 25, 2023 | 4:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Guggenheim analyst maintains a 'Buy' rating on Exelixis and raises the price target from $27 to $30.
The news of Guggenheim maintaining a 'Buy' rating and raising the price target for Exelixis is likely to instill confidence in investors and could potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100